shipment_ID,catalog_ID,Formula,stereochemistry,sample_MW,purity,PO,Salt_Name,Salt_ratio,MW_salt,volume(uL),concentration(mM),plate_ID,well,SMILES,Name
ALP-POS-c0c213c9-9,Z4553589407,C27H24N6O2,Achiral,464.518,98.87,200415-FTE / COVID-19,,,0,40,20,1178796-Y40-11,03_A,CN1C=NC(CN(C(=O)C2=CN=NN2C=3C=CC=CC3)C=4C=CC(OCC=5C=CC=CC5)=CC4)=C1,"N-[4-(benzyloxy)phenyl]-N-[(1-methyl-1H-imidazol-4-yl)methyl]-1-phenyl-1H-1,2,3-triazole-5-carboxamide"
ALP-POS-c0c213c9-14,Z4553575183,C23H21N5O,Achiral,383.445,99,200415-FTE / COVID-19,,,0,40,20,1178796-Y40-11,03_B,CN1C=CC(CN(C(=O)CC=2C=CC=NC2)C=3C=CC(=CC3)C=4C=CC=CN4)=N1,N-[(1-methyl-1H-pyrazol-3-yl)methyl]-N-[4-(pyridin-2-yl)phenyl]-2-(pyridin-3-yl)acetamide
ALP-POS-c0c213c9-12,Z4553564299,C20H24N6O2S,Achiral,412.508,98,200415-FTE / COVID-19,,,0,40,20,1178796-Y40-11,03_C,NCC1=CN(CC(=O)N(CC=2C=CSC2)C=3C=CC(=CC3)N4CCOCC4)N=N1,"2-[4-(aminomethyl)-1H-1,2,3-triazol-1-yl]-N-[4-(morpholin-4-yl)phenyl]-N-[(thiophen-3-yl)methyl]acetamide"
LON-WEI-babf2c61-4,Z4509080674,C28H30FN3O3,Racemic or presumed racemic or meso,475.554,90.75,200415-FTE / COVID-19,,,0,40,20,1178796-Y40-11,03_D,CC(C)(C)C=1C=CC(=CC1)N(C(C(=O)NCCC=2C=CC=C(F)C2)C=3C=NC=C(O)C3)C(=O)C=C,N-(4-tert-butylphenyl)-N-({[2-(3-fluorophenyl)ethyl]carbamoyl}(5-hydroxypyridin-3-yl)methyl)prop-2-enamide
LON-WEI-babf2c61-8,Z4509080711,C25H21F4N3O3,Racemic or presumed racemic or meso,487.446,100,200415-FTE / COVID-19,,,0,40,20,1178796-Y40-11,03_E,OC=1C=NC=C(C1)C(N(C(=O)C=C)C=2C=CC(=CC2)C(F)(F)F)C(=O)NCCC=3C=CC=C(F)C3,N-({[2-(3-fluorophenyl)ethyl]carbamoyl}(5-hydroxypyridin-3-yl)methyl)-N-[4-(trifluoromethyl)phenyl]prop-2-enamide
VLA-UCB-00f2c2b3-2,Z1951831918,C15H14N4O,Achiral,266.297,83.39,200415-FTE / COVID-19,,,0,40,20,1178796-Y40-11,03_F,CC=1C=CN=CC1NC(=O)CC=2C=CC=3NN=CC3C2,2-(1H-indazol-5-yl)-N-(4-methylpyridin-3-yl)acetamide
BEN-BAS-f6e16b09-1,Z3347909109,C22H23NO4,Diastereomeric mixture,365.422,86.22,200415-FTE / COVID-19,,,0,40,20,1178796-Y40-11,03_G,OC(=O)C1(CC2(CNCC=3C=CC=4CCOC4C3)C1)C(O2)C=5C=CC=CC5,"1-({[(2,3-dihydro-1-benzofuran-6-yl)methyl]amino}methyl)-3-phenyl-2-oxabicyclo[2.1.1]hexane-4-carboxylic acid"
ADA-UCB-6c2cb422-3,Z2595889736,C17H19N3O,Achiral,281.352,98.87,200415-FTE / COVID-19,,,0,40,20,1178796-Y40-11,03_H,CC=1C=CN=CC1CC(=O)NC=2C=CC=C3CCNCC23,"2-(4-methylpyridin-3-yl)-N-(1,2,3,4-tetrahydroisoquinolin-8-yl)acetamide"
COM-UCB-8c7d23dc-1,Z56801196,C13H10FN5O2,Achiral,287.249,100,200415-FTE / COVID-19,,,0,40,20,1178796-Y40-11,03_I,FC=1C=CC=CC1OCC(=O)NC=2N=CN=C3NC=NC23,2-(2-fluorophenoxy)-N-(9H-purin-6-yl)acetamide
COM-UCB-8c7d23dc-18,Z1647884510,C17H15N5O3,Achiral,337.332,100,200415-FTE / COVID-19,,,0,40,20,1178796-Y40-11,03_J,CC=1NC=2N=CN=C(NC(=O)C=3C=CC=C4N(C)C(=O)OC34)C2C1C,"N-{5,6-dimethyl-7H-pyrrolo[2,3-d]pyrimidin-4-yl}-3-methyl-2-oxo-2,3-dihydro-1,3-benzoxazole-7-carboxamide"
COM-UCB-8c7d23dc-16,Z1592200190,C19H21ClN6O,Achiral,384.862,91.16,200415-FTE / COVID-19,,,0,40,20,1178796-Y40-11,03_K,CC=1NC=2N=CN=C(NC(=O)C3CCN(CC3)C=4C=CC(Cl)=CN4)C2C1C,"1-(5-chloropyridin-2-yl)-N-{5,6-dimethyl-7H-pyrrolo[2,3-d]pyrimidin-4-yl}piperidine-4-carboxamide"
COM-UCB-8c7d23dc-13,Z2320545771,C15H16FN5O2,Racemic or presumed racemic or meso,317.318,100,200415-FTE / COVID-19,,,0,40,20,1178796-Y40-11,03_L,FC=1C=C(C=CC1NC(=O)C2CCCCC(=O)N2)C=3N=CNN3,"N-[2-fluoro-4-(1H-1,2,4-triazol-3-yl)phenyl]-7-oxoazepane-2-carboxamide"
COM-UCB-8c7d23dc-12,Z2000233694,C18H14N4O3,Achiral,334.328,91.6,200415-FTE / COVID-19,,,0,40,20,1178796-Y40-11,03_M,CC=1NC=2N=CN=C(NC(=O)C3=CC=4C=CC=CC4C(=O)O3)C2C1C,"N-{5,6-dimethyl-7H-pyrrolo[2,3-d]pyrimidin-4-yl}-1-oxo-1H-isochromene-3-carboxamide"
COM-UCB-8c7d23dc-7,Z1926900620,C21H22N4O2,Racemic or presumed racemic or meso,362.424,100,200415-FTE / COVID-19,,,0,40,20,1178796-Y40-11,03_N,CN1C(=NC=2C=CC=CC12)C=3C=CC(NC(=O)C4CCCCC(=O)N4)=CC3,"N-[4-(1-methyl-1H-1,3-benzodiazol-2-yl)phenyl]-7-oxoazepane-2-carboxamide"
COM-UCB-8c7d23dc-6,Z909652136,C16H16N6O,Racemic or presumed racemic or meso,308.337,95.95,200415-FTE / COVID-19,,,0,40,20,1178796-Y40-11,03_O,O=C1C(CCN1CC=2C=CC=CC2)NC=3N=CN=C4N=CNC34,1-benzyl-3-[(7H-purin-6-yl)amino]pyrrolidin-2-one
COM-UCB-8c7d23dc-15,Z1559986976,C16H12N6O,Achiral,304.306,100,200415-FTE / COVID-19,,,0,40,20,1178796-Y40-11,03_P,O=C(NC1=CNN=C1C=2C=CC=CN2)C3=CC=CC4=NC=CN34,"N-[3-(pyridin-2-yl)-1H-pyrazol-4-yl]imidazo[1,2-a]pyridine-5-carboxamide"
EDJ-MED-2c295496-1,Z2077729193,C15H16N4O2,Racemic or presumed racemic or meso,284.313,100,200415-FTE / COVID-19,,,0,40,20,1178796-Y40-11,04_A,O=C(NC1=NN=CN1C2CC2)C3CCOC=4C=CC=CC34,"N-(4-cyclopropyl-4H-1,2,4-triazol-3-yl)-3,4-dihydro-2H-1-benzopyran-4-carboxamide"
BRU-THA-a358fbdd-7,Z2841210530,C15H15FN4O2,Racemic or presumed racemic or meso,302.303,100,200415-FTE / COVID-19,,,0,40,20,1178796-Y40-11,04_B,FC=1C=CC=C2C(CCOC12)C(=O)NC3=NN=CN3C4CC4,"N-(4-cyclopropyl-4H-1,2,4-triazol-3-yl)-8-fluoro-3,4-dihydro-2H-1-benzopyran-4-carboxamide"
JOH-UNI-a5c0a47e-3,Z2312478812,C16H18ClNO4S,Diastereomeric mixture,355.836,85,200415-FTE / COVID-19,,,0,40,20,1178796-Y40-11,04_C,COC(=O)C(N1CCC(S)/C(=C/C(=O)O)/C1)C=2C=CC=CC2Cl,2-[(3E)-1-[1-(2-chlorophenyl)-2-methoxy-2-oxoethyl]-4-sulfanylpiperidin-3-ylidene]acetic acid
LON-WEI-adc59df6-78,Z4459610252,C23H26N4O2,Racemic or presumed racemic or meso,390.478,100,200415-FTE / COVID-19,,,0,40,20,1178796-Y40-11,04_D,CC(C)(C)NC(=O)C(N(C(=O)C=C)C=1C=CC(CCC#N)=CC1)C=2C=CC=NC2,N-[(tert-butylcarbamoyl)(pyridin-3-yl)methyl]-N-[4-(2-cyanoethyl)phenyl]prop-2-enamide